Funding
1 min read
Limbic raised $14M led by Khosla Ventures, backed by a Nature Medicine study showing its AI therapy...
The AMW Read
The article provides clinical validation for AI agents in a high-stakes vertical, advancing the debate from simple LLM wrappers to specialized reasoning layers that outperform human baselines.
NoveltySignificance
Healthcare & Bio · Player MapAI Agents · Definition
Limbic raised $14M led by Khosla Ventures, backed by a Nature Medicine study showing its AI therapy agents outperformed human therapists in CBT delivery across 20,000 conversations with 227 participants. The AI's clinical reasoning layer scored higher than both licensed clinicians and standalone LLMs from OpenAI, Anthropic, Google and Meta. Prior NHS trials also showed 42% higher therapy attendance and 25% better recovery rates. This signals a shift where domain-specific AI layers on top of foundation models can scale quality mental healthcare beyond human capacity. 🧠